Nevertheless, because such strategies based on tumor protein lysate can lead to off-target unpredictable immune reactions, some vaccine trials have been carried out to target the few immunogenic antigens that have been described in HCC such as alpha-fetoprotein (AFP) and glypican-3 (GPC-3).22, 23. This evidence concerns the gene AFP and neoplasm.